Register for our free email digests:
Harpoon Medical Inc.
Division of Edwards Lifesciences Corp.
www.harpoonmedical.com
Latest From Harpoon Medical Inc.
Market Brief: Innovation Will Drive 13% Growth In Global Transcatheter Mitral Valve Repair Market by 2023, Outpacing Growth Of TAVR
The transcatheter heart valve management products market will reach $6.7bn by 2023, driven by the rising prevalence of heart disease. Transcatheter aortic valve replacement (TAVR) procedures lead the market, but innovation and rising competition, including from companies in China and India, will fuel double-digit growth in the much smaller mitral valve repair market, dominated by Abbott's MitraClip.
Edwards Invests In Mitral, Tricuspid Solutions As TAVR Growth Exceeds Expectations
Sales of Sapien transcatheter aortic valves grew about 27% year over year in the third quarter of 2019 while revenues from Edwards’ transcatheter mitral and tricuspid therapies grew to almost $10m, led by sales of the Pascal transcatheter mitral repair system in Europe.
Global Approvals Analysis: Emerging Markets Drive Volume Of OUS Approvals
The numbers of medical device approvals were up in most regions outside the US and the biggest surge, by percentage, was in approvals from emerging markets and the so-called BRIC countries. It remains to be seen if the trend will continue in 2018, but many companies are already counting on important non-US approvals coming in the next year.
Deals Shaping the Medical Industry, January 2018
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in December 2017.
Company Information
- Industry
-
Medical Devices
- Diagnostic Imaging Equipment & Supplies
-
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Cardiovascular
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Edwards Lifesciences Corp.
- Senior Management
-
Bill Niland, Pres. & CEO
Peter Wilson, VP, R&D
Peter Boyd, VP, Bus. Dev.
Mark Collins, VP, Fin. & Operations - Contact Info
-
Harpoon Medical Inc.
Phone: (410) 346-5687
351 West Camden St.
Ste. 801
Baltimore, MD 21201
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice